theophylline has been researched along with sirolimus in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Lawrence, JC; Scott, PH | 1 |
| Akdis, CA; Akdis, M; Blaser, K; Bröcker, EB; Disch, R; Schmid-Grendelmeier, P; Trautmann, A | 1 |
| Barilli, A; Bonomini, S; Bussolati, O; Closs, EI; Dall'Asta, V; Gazzola, GC; Parolari, A; Sala, R; Simon, A; Tremoli, E; Visigalli, R | 1 |
1 review(s) available for theophylline and sirolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 other study(ies) available for theophylline and sirolimus
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Attenuation of mammalian target of rapamycin activity by increased cAMP in 3T3-L1 adipocytes.
Topics: 3T3 Cells; Adaptor Proteins, Signal Transducing; Adipocytes; Amino Acid Sequence; Animals; Carrier Proteins; Cell Cycle Proteins; Colforsin; Cyclic AMP; Eukaryotic Initiation Factors; Immunoassay; Insulin; Intracellular Signaling Peptides and Proteins; Mice; Molecular Sequence Data; Peptide Fragments; Peptide Mapping; Phosphoproteins; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Protein Kinases; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Recombinant Proteins; Repressor Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Sirolimus; Theophylline; Thionucleotides; TOR Serine-Threonine Kinases | 1998 |
Targeting keratinocyte apoptosis in the treatment of atopic dermatitis and allergic contact dermatitis.
Topics: Acute Disease; Apoptosis; Cells, Cultured; Cyclosporine; Dermatitis, Allergic Contact; Dermatitis, Atopic; Dexamethasone; fas Receptor; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interleukin-12; Keratinocytes; Sirolimus; T-Lymphocytes; Tacrolimus; Th1 Cells; Theophylline | 2001 |
In human endothelial cells rapamycin causes mTORC2 inhibition and impairs cell viability and function.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Blotting, Western; Cardiovascular Agents; Carrier Proteins; Caspase 3; Cell Movement; Cell Survival; Dose-Response Relationship, Drug; E-Selectin; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Humans; Immunoprecipitation; L-Lactate Dehydrogenase; Mechanistic Target of Rapamycin Complex 1; Microscopy, Confocal; Multiprotein Complexes; Necrosis; Nitric Oxide; Nitric Oxide Synthase Type III; Polymerase Chain Reaction; Protein Kinases; Proteins; Rapamycin-Insensitive Companion of mTOR Protein; Regulatory-Associated Protein of mTOR; Ribosomal Protein S6 Kinases, 70-kDa; Sirolimus; Stress Fibers; Tacrolimus; Theophylline; Time Factors; TOR Serine-Threonine Kinases; Transcription Factors; Tumor Necrosis Factor-alpha; Up-Regulation | 2008 |